FURIEX PHARMACEUTICALS INC has a total of 16 patent applications. Its first patent ever was published in 2008. It filed its patents most often in Japan, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are NEUROCYCLE THERAPEUTICS INC, SPERO TRINEM INC and SCIFLUOR LIFE SCIENCES LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 3 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | China | 1 | |
#5 | EAPO (Eurasian Patent Organization) | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | Nicaragua | 1 | |
#10 | Taiwan | 1 | |
#11 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Feibush Penina | 7 |
#2 | Villani Frank J | 7 |
#3 | Anzalone Luigi | 7 |
#4 | Fegely Barry | 7 |
#5 | Barry Fegely | 4 |
#6 | Penina Feibush | 4 |
#7 | Teleha Christopher Allan | 4 |
#8 | Luigi Anzalone | 4 |
#9 | Christopher Allan Teleha | 4 |
#10 | Frank J Villani | 4 |
Publication | Filing date | Title |
---|---|---|
TW201444590A | Dosage formulation of opioid receptor modulator | |
WO2011153247A1 | Combination therapies | |
EA020024B1 | Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)ethyl]amino}methyl)-2-methoxybenzoic acid |